Udg Healthcare PLC (LON:UDG) had its price objective increased by equities research analysts at Berenberg Bank from GBX 655 ($8.55) to GBX 700 ($9.14) in a report released on Friday. The firm presently has a “buy” rating on the stock. Berenberg Bank’s price objective suggests a potential upside of 8.28% from the stock’s current price.
Other equities analysts have also issued research reports about the stock. Goodbody reaffirmed a “buy” rating on shares of Udg Healthcare PLC in a research note on Thursday, August 4th. Jefferies Group raised their price objective on shares of Udg Healthcare PLC from GBX 680 ($8.88) to GBX 720 ($9.40) and gave the stock a “buy” rating in a research note on Friday, September 30th. Stifel Nicolaus reaffirmed a “hold” rating and issued a GBX 620 ($8.09) price objective on shares of Udg Healthcare PLC in a research note on Wednesday, September 28th. Numis Securities Ltd reaffirmed an “add” rating and issued a GBX 675 ($8.81) price objective on shares of Udg Healthcare PLC in a research note on Thursday, August 4th. Finally, Davy Research reaffirmed an “outperform” rating on shares of Udg Healthcare PLC in a research note on Thursday, August 4th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of GBX 666 ($8.69).
Udg Healthcare PLC (LON:UDG) opened at 646.50 on Friday. Udg Healthcare PLC has a one year low of GBX 452.20 and a one year high of GBX 663.00. The firm has a 50-day moving average price of GBX 631.53 and a 200 day moving average price of GBX 602.83. The firm’s market capitalization is GBX 1.59 billion.
In other Udg Healthcare PLC news, insider Chris Corbin sold 90,849 shares of the stock in a transaction that occurred on Monday, September 26th. The shares were sold at an average price of GBX 634 ($8.28), for a total value of £575,982.66 ($751,837.44).
About Udg Healthcare PLC
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.
Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.